Serial lactate determinations during circulatory shock

Critical Care Medicine
J L VincentR J Kahn

Abstract

The time course of lactacidemia was studied prospectively in 17 patients during fluid resuscitation for an episode of noncardiogenic shock, in 5 patients after grand mal seizures, and in 5 patients after successful CPR for cardiac arrest. The 9 patients in whom shock was reversed with fluid administration demonstrated a regular decrease in lactate concentrations, which exceeded 5% of the initial value during the first 60 min of treatment. In the other patients who expired despite similar therapy, lactacidemia was not significantly affected. During circulatory shock, repeated lactate determinations represent a more reliable prognostic index than an initial value taken alone. Changes in lactate concentration can provide an early and objective evaluation of the patient's response to therapy.

Citations

Jul 1, 1989·International Journal of Clinical Monitoring and Computing·J L VincentR J Kahn
Jan 1, 1986·Annals of Biomedical Engineering·J Boyle
May 1, 1996·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J L Vincent
May 11, 2011·Der Anaesthesist·O GrottkeR Rossaint
Jul 10, 2007·Intensive Care Medicine·Jan Bakker, Tim C Jansen
Oct 22, 2010·Analytical and Bioanalytical Chemistry·Anthony Guiseppi-Elie
Jan 1, 1990·The International Journal of Biochemistry·J Korf, J de Boer
Apr 22, 1999·Clinical Biochemistry·M H de KeijzerP G Brans
Mar 1, 1997·Journal of Critical Care·J A KellumM R Pinsky
Jun 8, 2001·European Journal of Internal Medicine·J A.S. BallE D. Bennett
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·Ednan K BajwaB Taylor Thompson
Feb 2, 1984·The New England Journal of Medicine·J L Vincent
May 20, 1993·The New England Journal of Medicine·J E Parrillo
Nov 1, 2013·The New England Journal of Medicine·Jean-Louis Vincent, Daniel De Backer
Sep 28, 2001·British Journal of Anaesthesia·M Palazzo
Feb 1, 1995·Critical Care Medicine·J C PreiserJ L Vincent
Nov 5, 1999·Critical Care Medicine·T Shirey, M Sivilotti
Aug 31, 2000·Critical Care Medicine·D LeDouxE C Rackow
Aug 3, 2004·Critical Care Medicine·H Bryant NguyenMichael C Tomlanovich
Sep 3, 2004·Critical Care Medicine·Steven M HollenbergSergio Zanotti-Cavazzoni
Nov 16, 2004·Critical Care Medicine·Richard J BealeJoseph E Parrillo
Nov 16, 2004·Critical Care Medicine·Jean-Louis Vincent, Herwig Gerlach
Sep 3, 2004·Medicine·Andreas KliegelAnton N Laggner
May 25, 2006·Current Opinion in Pediatrics·Elliot Melendez, Richard Bachur
Oct 30, 2004·The Journal of Trauma·Samuel A TishermanRonald Simon
Mar 28, 2009·Critical Care Medicine·Mark E MikkelsenJason D Christie
May 25, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jill M CholetteNorma B Lerner
Jan 4, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Meredith Allen
Jan 1, 1993·Acta Anaesthesiologica Scandinavica. Supplementum·J L Vincent
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·J L Vincent
Jan 1, 1997·Acta Anaesthesiologica Scandinavica. Supplementum·J L Vincent
Sep 7, 2007·Veterinary Clinical Pathology·Connie K StevensonMarion L Jackson
Sep 18, 1999·Archives of Disease in Childhood·T Duke
May 25, 2005·Emergency Medicine Journal : EMJ·G J Rodrigo, C Rodrigo
Oct 24, 2006·Emergency Medicine Journal : EMJ·A D ReubenN I Shapiro
Jan 1, 1997·Archives of Disease in Childhood. Fetal and Neonatal Edition·S A Deshpande, M P Platt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.